Association of TGFB1 -509 C>T polymorphism with breast cancer: Evidence from a meta-analysis involving 23,579 subjects

Breast Cancer Research and Treatment

Volumn 124, Issue 1, 2010, Pages 243-249

  Niu, Wenquan ^a   Qi, Yue ^b   Gao, Pingjin ^a   Zhu, Dingliang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

509 C>T; Association; Breast cancer; Meta analysis; Transforming growth factor beta 1 gene (TGFB1)

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; ETHNICITY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; PATHOGENESIS; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77957715706     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0832-0     Document Type: Article

References (22)

1. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 533 543 1:STN:280:DC%2BD387ntlCrtw%3D%3D 10.1016/S1470-2045(01)00486-7 11905707
2. AC Antoniou PD Pharoah G McMullan NE Day BA Ponder D Easton 2001 Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genet Epidemiol 21 1 18 1:STN:280: DC%2BD3MzovVGltQ%3D%3D 10.1002/gepi.1014 11443730
3. L Feuk AR Carson SW Scherer 2006 Structural variation in the human genome Nat Rev Genet 7 85 97 1:CAS:528:DC%2BD28XkvFOjuw%3D%3D 10.1038/nrg1767 16418744
4. FF Parl S Dawling N Roodi PS Crooke 2009 Estrogen metabolism and breast cancer: a risk model Ann N Y Acad Sci 1155 68 75 1:CAS:528:DC%2BD1MXktFKlsbo%3D 10.1111/j.1749-6632.2008.03676.x 19250193
5. M Ahmed F Lalloo DG Evans 2009 Update on genetic predisposition to breast cancer Expert Rev Anticancer Ther 9 1103 1113 1:CAS:528:DC%2BD1MXpvF2qurk%3D 10.1586/era.09.38 19671030
6. DJ Grainger K Heathcote M Chiano H Snieder PR Kemp JC Metcalfe ND Carter TD Spector 1999 Genetic control of the circulating concentration of transforming growth factor type beta1 Hum Mol Genet 8 93 97 1:CAS:528:DyaK1MXoslChsw%3D%3D 10.1093/hmg/8.1.93 9887336
7. A Shin XO Shu Q Cai YT Gao W Zheng 2005 Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages Cancer Epidemiol Biomarkers Prev 14 1567 1570 1:CAS:528:DC%2BD2MXkvVCkurg%3D 10.1158/1055-9965.EPI-05-0078 15941974
8. AM Dunning PD Ellis S McBride HL Kirschenlohr CS Healey PR Kemp RN Luben J Chang-Claude A Mannermaa V Kataja PD Pharoah DF Easton BA Ponder JC Metcalfe 2003 A transforming growth factor beta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer Cancer Res 63 2610 2615 1:CAS:528:DC%2BD3sXjsleht7w%3D 12750287
9. Q Jin K Hemminki E Grzybowska R Klaes M Söderberg H Zientek J Rogozinska-Szczepka B Utracka-Hutka J Pamula W Pekala A Försti 2004 Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers Int J Cancer 112 94 99 1:CAS:528:DC%2BD2cXnvVWlsbk%3D 10.1002/ijc.20370 15305380
10. DG Cox K Penney Q Guo SE Hankinson DJ Hunter 2007 TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study BMC Cancer 7 175 10.1186/1471-2407-7-175 17848193
11. A Jakubowska K Jaworska C Cybulski A Janicka J Szymańska-Pasternak M Lener SA Narod J Lubiński IHCC-Breast Cancer Study Group 2009 Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45 837 842 1:CAS:528:DC%2BD1MXisl2rsLY%3D 10.1016/j.ejca.2008.10.021 19071013
12. The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2009) Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0489-8
13. JP Higgins SG Thompson JJ Deeks DG Altman 2003 Measuring inconsistency in meta-analyses BMJ 327 557 560 10.1136/bmj.327.7414.557 12958120
14. LD Cohn BJ Becker 2003 How meta-analysis increases statistical power Psychol Methods 8 243 253 10.1037/1082-989X.8.3.243 14596489
15. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, Chichester, UK
16. KE Lohmueller CL Pearce M Pike ES Lander JN Hirschhorn 2003 Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease Nat Genet 33 177 182 1:CAS:528: DC%2BD3sXnsFSltQ%3D%3D 10.1038/ng1071 12524541
17. DJ Grainger CM Witchell JC Metcalfe 1995 Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta Nat Med 1 1067 1073 1:CAS:528:DyaK2MXosVGnsr4%3D 10.1038/nm1095-1067 7489365
18. E Janda K Lehmann I Killisch M Jechlinger M Herzig J Downward H Beug S Grünert 2002 Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways J Cell Biol 156 299 313 1:CAS:528:DC%2BD38XosFClsA%3D%3D 10.1083/jcb.200109037 11790801
19. RB Dickson A Kasid KK Huff SE Bates C Knabbe D Bronzert EP Gelmann ME Lippman 1987 Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene Proc Natl Acad Sci USA 8 837 841 10.1073/pnas.84.3.837
20. CS Greene NM Penrod SM Williams JH Moore 2009 Failure to replicate a genetic association may provide important clues about genetic architecture PLoS One 4 e5639 10.1371/journal.pone.0005639 19503614
21. Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao ZM (2009) Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0706-5
22. Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC (2010) Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0777-3